BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6114997)

  • 21. Direct measurement of ACh release from exposed frog nerve terminals: constraints on interpretation of non-quantal release.
    Grinnell AD; Gundersen CB; Meriney SD; Young SH
    J Physiol; 1989 Dec; 419():225-51. PubMed ID: 2621630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Frog Motor Nerve Terminal Has Very Brief Action Potentials and Three Electrical Regions Predicted to Differentially Control Transmitter Release.
    Ginebaugh SP; Cyphers ED; Lanka V; Ortiz G; Miller EW; Laghaei R; Meriney SD
    J Neurosci; 2020 Apr; 40(18):3504-3516. PubMed ID: 32265260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of intracellular Ca2+ in stimulation-induced increases in transmitter release at the frog neuromuscular junction.
    Zengel JE; Sosa MA; Poage RE; Mosier DR
    J Gen Physiol; 1994 Aug; 104(2):337-55. PubMed ID: 7807052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vesicle size and transmitter release at the frog neuromuscular junction when quantal acetylcholine content is increased or decreased.
    Van der Kloot W; Molgó J; Cameron R; Colasante C
    J Physiol; 2002 Jun; 541(Pt 2):385-93. PubMed ID: 12042346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cadmium: effects on transmitter release at the frog neuromuscular junction.
    Cooper GP; Manalis RS
    Eur J Pharmacol; 1984 Apr; 99(4):251-6. PubMed ID: 6145600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of changes in motor unit size on transmitter release at the frog neuromuscular junction.
    Herrera AA; Grinnell AD
    J Neurosci; 1985 Jul; 5(7):1896-900. PubMed ID: 2862227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraterminal Ca(2+) and spontaneous transmitter release at the frog neuromuscular junction.
    Angleson JK; Betz WJ
    J Neurophysiol; 2001 Jan; 85(1):287-94. PubMed ID: 11152728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between quantal secretion and vesicle loss at the frog neuromuscular junction.
    Hurlbut WP; Iezzi N; Fesce R; Ceccarelli B
    J Physiol; 1990 Jun; 425():501-26. PubMed ID: 2120425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in miniature endplate potential frequency during repetitive nerve stimulation in the presence of Ca2+, Ba2+, and Sr2+ at the frog neuromuscular junction.
    Zengel JE; Magleby KL
    J Gen Physiol; 1981 May; 77(5):503-29. PubMed ID: 6262429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciguatoxin enhances quantal transmitter release from frog motor nerve terminals.
    Molgó J; Comella JX; Legrand AM
    Br J Pharmacol; 1990 Apr; 99(4):695-700. PubMed ID: 1972891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of glycerol treatment on transmitter release at the frog neuromuscular junction.
    Sosa MA; Zengel JE
    Brain Res; 1993 Sep; 621(1):17-24. PubMed ID: 8106114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
    Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
    J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The action of the sodium ionophore, monensin, or transmitter release at the frog neuromuscular junction.
    Meiri H; Erulkar SD; Lerman T; Rahamimoff R
    Brain Res; 1981 Jan; 204(1):204-8. PubMed ID: 6113873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in MEPP frequency during depression of evoked release at the frog neuromuscular junction.
    Zengel JE; Sosa MA
    J Physiol; 1994 Jun; 477(Pt 2):267-77. PubMed ID: 7932218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The kinetics of transmitter release at the frog neuromuscular junction.
    Barrett EF; Stevens CF
    J Physiol; 1972 Dec; 227(3):691-708. PubMed ID: 4405553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ATP-sensitive K(+)-channel activators on transmitter release parameters at the frog neuromuscular junction.
    Salgado D; Shek EW; Alkadhi KA
    Brain Res; 1993 Apr; 609(1-2):307-12. PubMed ID: 8099524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of trifluoperazine and promethazine on the release of transmitter quanta at the mouse neuromuscular junction.
    Nishimura M; Komatsu R; Taquahashi Y; Shimizu Y; Satoh E
    J Peripher Nerv Syst; 1998; 3(2):111-5. PubMed ID: 10959244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction.
    Naves LA; Van der Kloot W
    J Physiol; 2001 May; 532(Pt 3):637-47. PubMed ID: 11313435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.